North Korea is to draw up "realistic" trade plans for increasing its drug exports, says O Thae Bong, vice president of the Committee for the Promotion of International trade of North Korea, quoted in The Pyongyang Times.
The export drive will focus particularly on southeast Asia, the Middle East, China, Russia and eastern Europe, but trade will also increase with the European Union and Latin and Central America. The official said North Korean medicines are in high demand overseas, and their quality will be improved further. Trade relations with foreign countries will be developed and expanded, and joint ventures and technology exchanges set up, he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze